Immuneering (IMRX) Preferred Shares Issued (2020)
Immuneering (IMRX) has 1 years of Preferred Shares Issued data on record, last reported at $37.2 million in Q4 2020.
- For Q4 2020, Preferred Shares Issued changed N/A year-over-year to $37.2 million; the TTM value through Dec 2021 reached $37.2 million, changed N/A, while the annual FY2021 figure was $24.8 million, 2383.09% up from the prior year.
- Preferred Shares Issued reached $37.2 million in Q4 2020 per IMRX's latest filing.
- Across five years, Preferred Shares Issued topped out at $37.2 million in Q4 2020 and bottomed at $37.2 million in Q4 2020.